Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study

Not Applicable

Completed

• Conditions: Cryptosporidiosis; HIV Infections

• Registration Number: NCT00002082
• Lead Sponsor: Pfizer

Brief Summary

To evaluate the safety and efficacy of azithromycin in the treatment of intestinal cryptosporidial infection in AIDS patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 1996-04
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (4)

Univ of Tennessee; 🇺🇸 Memphis, Tennessee, United States

Cornell Univ Med Ctr; 🇺🇸 New York, New York, United States

Infectious Disease Med Group; 🇺🇸 Oakland, California, United States

UCSD Med Ctr; 🇺🇸 San Diego, California, United States